| Previous close | 1.44 |
| Open | 1.44 |
| Day's range | 1.43 to 1.49 |
| 52-week range | 0.8500 to 2.23 |
| Volume | 413.4K |
| Average volume (3 months) | 435.5K |
| 1-year price change | +1.41% |
| Market value | 36.76M |
| EPS (last 12 months) | -0.43 |
| Beta (1 year) | 2.12 |
| Dividend yield | None |
Company figures come from SEC filings through the quarter ending Mar 31, 2026. All statistics
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
For learning only, not investment advice. Chart by TradingView. How to read a stock quote.